Staley Capital Advisers Inc. Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC)

Staley Capital Advisers Inc. trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 52.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,534 shares of the company’s stock after selling 5,048 shares during the quarter. Staley Capital Advisers Inc.’s holdings in Henry Schein were worth $314,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. Daiwa Securities Group Inc. grew its holdings in shares of Henry Schein by 5.4% during the fourth quarter. Daiwa Securities Group Inc. now owns 16,486 shares of the company’s stock worth $1,141,000 after purchasing an additional 850 shares in the last quarter. Isthmus Partners LLC boosted its holdings in shares of Henry Schein by 2.8% in the 4th quarter. Isthmus Partners LLC now owns 9,888 shares of the company’s stock worth $684,000 after purchasing an additional 266 shares in the last quarter. Amundi increased its position in shares of Henry Schein by 12.0% during the 4th quarter. Amundi now owns 736,637 shares of the company’s stock valued at $52,345,000 after purchasing an additional 79,056 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in Henry Schein by 0.5% in the 4th quarter. PNC Financial Services Group Inc. now owns 86,601 shares of the company’s stock worth $5,993,000 after buying an additional 458 shares during the last quarter. Finally, Edgestream Partners L.P. boosted its stake in Henry Schein by 119.5% in the fourth quarter. Edgestream Partners L.P. now owns 10,472 shares of the company’s stock worth $725,000 after buying an additional 5,702 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Performance

Shares of HSIC stock opened at $75.45 on Tuesday. The firm has a market capitalization of $9.37 billion, a price-to-earnings ratio of 31.05, a PEG ratio of 2.13 and a beta of 0.90. The stock has a fifty day moving average of $74.57 and a 200 day moving average of $72.59. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same period in the prior year, the business posted $0.66 earnings per share. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have commented on HSIC shares. Wells Fargo & Company began coverage on shares of Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. UBS Group reduced their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Finally, Barrington Research reissued an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.